Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johannes Laengle

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Cell Death Discovery|June 17, 2020
From threat to cure: understanding of virus-induced cell death leads to highly immunogenic oncolytic influenza virusesJulijan Kabiljo, Johannes Laengle, Michael Bergmann
Frontiers in Oncology|March 5, 2021
Surgical Complexity and Outcome During the Implementation Phase of a Robotic Colorectal Surgery Program-A Retrospective Cohort StudyCatharina Müller, Johannes Laengle, Stefan Riss, et al.
Seminars in Cancer Biology|June 7, 2022
Neoadjuvant immunotherapy in gastrointestinal cancers - The new standard of care?Branka Petricevic, Julijan Kabiljo, Rebecca Zirnbauer, et al.
Journal for Immunotherapy of Cancer|January 16, 2020
Histone deacetylase inhibitors valproic acid and vorinostat enhance trastuzumab-mediated antibody-dependent cell-mediated phagocytosisJohannes Laengle, Julijan Kabiljo, Leah Hunter, et al.
Antiviral Research|September 15, 2015
Interleukin-24 inhibits influenza A virus replication in vitro through induction of toll-like receptor 3 dependent apoptosisRené Weiss, Johannes Laengle, Monika Sachet, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|June 16, 2023
Liver surgery in the 2020s: ante-situm and in-situ resection are still indicated - A single-center studyMohammad H Fard-Aghaie, Johannes Laengle, Kim C Wagner, et al.
Surgery|November 6, 2016
Oncolytic influenza A virus expressing interleukin-15 decreases tumor growth in vivoKarin Hock, Johannes Laengle, Irina Kuznetsova, et al.
Journal of Translational Medicine|December 17, 2013
Trastuzumab mediates antibody-dependent cell-mediated cytotoxicity and phagocytosis to the same extent in both adjuvant and metastatic HER2/neu breast cancer patientsBranka Petricevic, Johannes Laengle, Josef Singer, et al.
Cell Metabolism|September 12, 2017
Exploring Metabolic Configurations of Single Cells within Complex Tissue MicroenvironmentsAnne Miller, Csörsz Nagy, Bernhard Knapp, et al.
Journal of Thoracic Disease|January 10, 2019
Mutational profile of colorectal cancer lung metastases and paired primary tumors by targeted next generation sequencing: implications on clinical outcome after surgeryThomas Schweiger, Sandra Liebmann-Reindl, Olaf Glueck, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Cell Death Discovery|June 17, 2020
From threat to cure: understanding of virus-induced cell death leads to highly immunogenic oncolytic influenza virusesJulijan Kabiljo, Johannes Laengle, Michael Bergmann
Frontiers in Oncology|March 5, 2021
Surgical Complexity and Outcome During the Implementation Phase of a Robotic Colorectal Surgery Program-A Retrospective Cohort StudyCatharina Müller, Johannes Laengle, Stefan Riss, et al.
Seminars in Cancer Biology|June 7, 2022
Neoadjuvant immunotherapy in gastrointestinal cancers - The new standard of care?Branka Petricevic, Julijan Kabiljo, Rebecca Zirnbauer, et al.
Journal for Immunotherapy of Cancer|January 16, 2020
Histone deacetylase inhibitors valproic acid and vorinostat enhance trastuzumab-mediated antibody-dependent cell-mediated phagocytosisJohannes Laengle, Julijan Kabiljo, Leah Hunter, et al.
Antiviral Research|September 15, 2015
Interleukin-24 inhibits influenza A virus replication in vitro through induction of toll-like receptor 3 dependent apoptosisRené Weiss, Johannes Laengle, Monika Sachet, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|June 16, 2023
Liver surgery in the 2020s: ante-situm and in-situ resection are still indicated - A single-center studyMohammad H Fard-Aghaie, Johannes Laengle, Kim C Wagner, et al.
Surgery|November 6, 2016
Oncolytic influenza A virus expressing interleukin-15 decreases tumor growth in vivoKarin Hock, Johannes Laengle, Irina Kuznetsova, et al.
Journal of Translational Medicine|December 17, 2013
Trastuzumab mediates antibody-dependent cell-mediated cytotoxicity and phagocytosis to the same extent in both adjuvant and metastatic HER2/neu breast cancer patientsBranka Petricevic, Johannes Laengle, Josef Singer, et al.
Cell Metabolism|September 12, 2017
Exploring Metabolic Configurations of Single Cells within Complex Tissue MicroenvironmentsAnne Miller, Csörsz Nagy, Bernhard Knapp, et al.
Journal of Thoracic Disease|January 10, 2019
Mutational profile of colorectal cancer lung metastases and paired primary tumors by targeted next generation sequencing: implications on clinical outcome after surgeryThomas Schweiger, Sandra Liebmann-Reindl, Olaf Glueck, et al.
Pageof 3